Hyperfine (HYPR) Net Margin (QoQ) (2021 - 2026)
Hyperfine (HYPR) Net Margin (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.79 Bn | 195.19 Bn | 7.27 Bn |
| 2 | Stryker | 125.96 Bn | 122.49 Bn | 4.50 Bn |
| 3 | Medtronic | 118.43 Bn | 109.21 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.13 Bn | 72.59 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.63 Bn | 47.38 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.71 Bn | 31.60 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.17 Bn | 22.85 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | Hyperfine | 88.70 Mn | 43.94 Mn | 1.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,723.00 |
| Mar 31, 2026 | -10,924.00 |
| Dec 31, 2025 | 20,890.00 |
| Sep 30, 2025 | 2,157.00 |
| Jun 30, 2025 | 9,854.00 |
| Mar 31, 2025 | 694.00 |
| Dec 31, 2024 | -16,420.00 |
| Sep 30, 2024 | -375.00 |
| Jun 30, 2024 | 1,917.00 |
| Mar 31, 2024 | 9,889.00 |
| Dec 31, 2023 | 6,391.00 |
| Sep 30, 2023 | -14,706.00 |
| Jun 30, 2023 | 14,687.00 |
| Mar 31, 2023 | 45,558.00 |
| Dec 31, 2022 | -35,612.00 |
| Sep 30, 2022 | 94,975.00 |
| Jun 30, 2022 | 6,485.00 |
| Mar 31, 2022 | 440,725.00 |
| Dec 31, 2021 | -156,447.00 |
| Sep 30, 2021 | -34,570.00 |